No Higher VTE Risk with Extendedcontinuous Estrogen in Combined OCs

03 Oct, 2018 ,

Among women starting combined oral contraceptives COCs the risk for venous thromboembolism VTE is not significantly higher with noncyclic estrogen use extended 84/7 days cycle and continuous 365/0 days cycle than with traditional cyclic estrogen use 21/7 days cycle according to a new safety analysis The literature is scant on the VTE risk difference between noncyclic and cyclic estrogen